PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
16.49%
Revenue growth exceeding 1.5x VET's 6.15%. David Dodd would verify if faster growth reflects superior business model.
2.20%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
31.21%
Gross profit growth 1.25-1.5x VET's 22.21%. Bruce Berkowitz would examine sustainability.
12.63%
Similar margin change to VET's 15.13%. Walter Schloss would investigate industry pricing power.
No Data
No Data available this quarter, please select a different quarter.
38.78%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
-1.88%
Other expenses reduction while VET shows 0.00% growth. Joel Greenblatt would examine efficiency.
2.32%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
2.27%
Total costs growth while VET reduces costs. John Neff would investigate differences.
-3.25%
Interest expense reduction while VET shows 54.34% growth. Joel Greenblatt would examine advantage.
-0.49%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-74.65%
EBITDA decline while VET shows 26.56% growth. Joel Greenblatt would examine position.
14.46%
Similar EBITDA margin growth to VET's 19.22%. Walter Schloss would investigate industry trends.
134.02%
Operating income growth 50-75% of VET's 179.03%. Martin Whitman would scrutinize operations.
129.20%
Similar operating margin growth to VET's 162.86%. Walter Schloss would investigate industry trends.
-851.22%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
148.15%
Pre-tax income growth exceeding 1.5x VET's 71.96%. David Dodd would verify competitive advantages.
141.33%
Pre-tax margin growth exceeding 1.5x VET's 61.99%. David Dodd would verify competitive advantages.
199.17%
Tax expense growth above 1.5x VET's 72.00%. Michael Burry would check for concerning trends.
285.71%
Net income growth exceeding 1.5x VET's 71.92%. David Dodd would verify competitive advantages.
259.42%
Net margin growth exceeding 1.5x VET's 61.96%. David Dodd would verify competitive advantages.
282.76%
EPS growth exceeding 1.5x VET's 66.67%. David Dodd would verify competitive advantages.
282.76%
Diluted EPS growth exceeding 1.5x VET's 76.47%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
0.18%
Diluted share reduction below 50% of VET's 0.00%. Michael Burry would check for concerns.